about
High Fat Diet-induced Breast Cancer Model in Rat.Identification of markers for imminent death in mice used in longevity and aging researchWelfare issues of genetically modified animals.Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast CancerTrials, tribulations, and trends in tumor modeling in mice.Health Evaluation of Experimental Laboratory MiceLeptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression.Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats.Endpoints for mouse abdominal tumor models: refinement of current criteria.Experimental liver fibrosis research: update on animal models, legal issues and translational aspects.Survival variability of controls and definition of imaging endpoints for longitudinal follow-up of pancreatic ductal adenocarcinoma in rats.Institutional Animal Care and Use Committee Considerations Regarding the Use of Virus-Induced Carcinogenesis and Oncolytic Viral Models.Retrospective Proteomic Analysis of a Novel, Cancer Metastasis-Promoting RGD-Containing Peptide.A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization.A quantitative and humane tail bleeding assay for efficacy evaluation of antihaemophilic factors in haemophilia A mice.Critical evaluation of challenges and future use of animals in experimentation for biomedical research.Cooperation of CD4+ T cells and CD8+ T cells and release of IFN-γ are critical for antileukemia responses of recipient mice treated by microtransplantation.A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer.Testing PARP Inhibitors Using a Murine Xenograft Model.Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy.
P2860
Q33738344-6AA43636-22C0-4C39-B61D-2C796AA8F5DCQ33880081-685D5F00-614A-4BC4-A12D-4C67A15FB673Q34578774-5F0D28F0-1BF7-499C-8331-7160E6D05EC5Q35533514-59D8C01D-3F11-45D8-9700-06FC9E9C3D4CQ35812510-4A3721EA-25DC-46D1-84C6-80FC50594A91Q36102497-E443E537-DB5E-4DA5-BF2C-593D29C44AAEQ36411081-38C1AEFB-490F-4C14-BDF0-CE9B79385ECEQ36597182-4B7398C0-86AD-4075-B752-EFD716984219Q37322375-F75C5A01-063B-4181-9B2A-E4E565977439Q37363773-EF18907E-13A8-4255-B1BC-B5EDE3B9D381Q38436041-F715D48B-9496-4105-B5E8-ABFE1EEFAA98Q40823356-5DB9D13B-7392-405A-9A51-8C2F4D2F80B2Q43235061-0B153E0F-8537-4059-98F3-02A5FA284B9EQ44114723-CA7083B4-726F-43FE-AEA8-F525CAC31933Q45866451-9A441FE5-8157-41C0-8B94-D3EC80897DFCQ46483251-0E94CBC1-9226-4171-8F45-500EB86A17C6Q49335346-F036263D-0C09-4DA9-8535-7CBD8A3AD459Q52341978-45383774-5C81-4EF7-86CF-0D16B986308DQ53170125-6967D1EC-EB51-417B-A017-90FD585F910FQ55156621-B49D07DA-9D53-45F5-AE9F-F5BAF3A7C74A
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Humane endpoints and cancer research.
@ast
Humane endpoints and cancer research.
@en
Humane endpoints and cancer research.
@nl
type
label
Humane endpoints and cancer research.
@ast
Humane endpoints and cancer research.
@en
Humane endpoints and cancer research.
@nl
prefLabel
Humane endpoints and cancer research.
@ast
Humane endpoints and cancer research.
@en
Humane endpoints and cancer research.
@nl
P356
P1433
P1476
Humane endpoints and cancer research.
@en
P2093
P356
10.1093/ILAR.41.2.87
P577
2000-01-01T00:00:00Z